Pharmaceuticals, Biotechnology and Life Sciences
TARRYTOWN, N.Y., Aug. 20, 2024 (GLOBE NEWSWIRE) — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and…
NEW YORK, Aug. 20, 2024 (GLOBE NEWSWIRE) — Eyenovia, Inc. (“Eyenovia” or the “Company”) (NASDAQ: EYEN), a commercial-stage ophthalmic company,…
REDWOOD CITY, Calif., Aug. 20, 2024 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced…
WARRINGTON, Pa., Aug. 20, 2024 (GLOBE NEWSWIRE) — Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused…
WATERTOWN, Mass., Aug. 20, 2024 (GLOBE NEWSWIRE) — Tectonic Therapeutic, Inc. (NASDAQ: TECX) (Tectonic), a clinical stage biotechnology company focused…
Appointment adds biotech veteran with over two decades of business development, strategy, and operational experience to Cidara’s management teamSAN DIEGO,…
COPENHAGEN, Denmark, August 17, 2024 – Bavarian Nordic A/S (OMX: BAVA) provides an update on plans for securing supply of…
SAN DIEGO and TORONTO, Aug. 15, 2024 (GLOBE NEWSWIRE) — Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX:…
Record Total Revenues of $236 million for the first six months of 2024, an over ten-fold increase compared to same…
Record Total Revenues of $236 million for the first six months of 2024, an over ten-fold increase compared to same…